Back to Trades
Buy4
Keenova Therapeutics plc
NONE
Total Value
$61.4M
Net $61.4M bought
Purchases
$61.4M
2 transactions
Company Information
- Company Name
- Keenova Therapeutics plc
- Ticker Symbol
- NONE
- CIK
- 0001567892
Insider Information
- Role
- Insider
- Location
- GREENWICH, CT
Filing Details
- Filing Date
- Apr 17, 2026
- Transaction Date
- Apr 15, 2026
- Accession Number
- 0001193125-26-161818
- Form Type
- 4
- Net Trading Amount
- $61.4M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 15, 2026 | Common Stock | 275,000 | $88.50 | Purchase | $24.3M |
| Apr 17, 2026 | Common Stock | 410,000 | $90.50 | Purchase | $37.1M |
Footnotes
- (F1)Silver Point Capital, L.P. ("Silver Point") or its wholly owned subsidiaries are the investment managers of Silver Point Capital Fund, L.P., Silver Point Capital Offshore Master Fund, L.P., Silver Point Distressed Opportunity Institutional Partners, L.P., Silver Point Distressed Opportunity Institutional Partners Master Fund (Offshore), L.P., Silver Point Distressed Opportunities Fund, L.P., Silver Point Distressed Opportunities Offshore Master Fund, L.P., Silver Point Distressed Opportunity Institutional Partners II, L.P. and Silver Point Distressed Opportunity Institutional Partners II (Offshore), L.P. (the "Funds") and, by reason of such status, may be deemed to be the beneficial owner of all the reported securities held by the Funds.
- (F2)(Continued from footnote 1) Silver Point Capital Management, LLC ("Management") is the general partner of Silver Point and as a result may be deemed to be the beneficial owner of all securities held by the Funds. Messrs. Edward A. Mule and Robert J. O'Shea are members of Management and as a result may each be deemed to be the beneficial owner of all of the securities held by the Funds. Messrs. Mule and O'Shea disclaim beneficial ownership of the reported securities held by Funds except to the extent of their pecuniary interests.